mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.002 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.002 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.002 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.003 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.003 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |